Nordicus Partners Corporation income statement NORD

It recorded a net loss of $4.0 million. Diluted earnings per share were -$0.22. Across the 4 fiscal years shown, revenue shrank from $2.3 million in fiscal 2017 to $5,000 in fiscal 2025, about 87.0% a year.

USD in millions, except per-share amounts and margins. The percent under a figure is the change from the year before.

Line
FY 2026
Mar 31, 2026
FY 2025
Mar 31, 2025
FY 2024
Mar 31, 2024
FY 2023
Mar 31, 2023
FY 2022
Mar 31, 2022
FY 2021
Mar 31, 2021
FY 2020
Mar 31, 2020
FY 2018
Mar 31, 2018
FY 2017
Mar 31, 2017
FY 2016
Mar 31, 2016
Revenue
—
0
+100.0%
0
—
—
—
—
0
-99.9%
2
-28.2%
—
Cost of revenue
—
—
—
—
—
—
—
1
-6.3%
1
-21.0%
—
Gross profit
—
—
—
—
—
—
—
0
-99.9%
1
-31.9%
—
Research and development
2
+20.9%
1
—
—
—
—
—
0
-99.9%
0
+6.1%
0
+0.0%
Selling, general and administrative
1
+168.3%
0
+510.6%
0
-72.4%
0
—
—
0
+17817.0%
0
-99.9%
1
-10.4%
—
Operating income
-4
-49.7%
-3
-849.1%
-0
+96.4%
-8
-2642.8%
-0
—
—
—
—
—
Interest expense
0
+221.0%
0
—
—
—
—
—
—
—
—
Gain (loss) on investments
0
+85.7%
0
—
—
—
—
—
—
—
—
Pretax income
-4
-38.7%
-3
-878.3%
-0
+96.5%
-8
-2850.2%
-0
+11.9%
-0
-32.5%
-0
-43.0%
—
—
—
Net income
-4
-37.9%
-3
-872.9%
-0
+96.5%
-8
-2850.2%
-0
+11.9%
-0
-106.0%
5
-0
+60.3%
-1
-1642.4%
0
+110.4%
Basic EPS
-0.22
+31.2%
-0.32
-10.3%
-0.29
+79.7%
-1.43
-376.7%
-0.30
+48.3%
-0.58
-352.2%
0.23
+1050.0%
-0.01
+50.0%
-0.02
—
Diluted EPS
-0.22
+31.2%
-0.32
-10.3%
-0.29
—
—
-0.01
-104.3%
0.23
+2200.0%
-0.01
+50.0%
-0.02
—
Weighted average shares, basic
18
+96.9%
9
+789.6%
1
-82.6%
6
+528.7%
1
+66.7%
1
-97.6%
24
+10.2%
0
+0.0%
0
—
Weighted average shares, diluted
18
+96.9%
9
+789.6%
1
—
—
28
+19.4%
24
+2.5%
0
+0.0%
0
-99.9%
—
Other measures
Depreciation and amortization
—
—
—
—
—
—
—
0
-99.9%
0
-25.0%
0
-39.7%
Interest coverage
-6,808.41x
-14,596.83x
—
—
—
—
—
—
—
—
Margins
Gross margin
—
—
—
—
—
—
—
72.62%
62.65%
—
Operating margin
—
-58,387.30%
-12,303.52%
—
—
—
—
—
—
—
Pretax margin
—
-58,345.60%
-11,928.08%
—
—
—
—
—
—
—
Profit margin
—
-58,026.42%
-11,928.08%
—
—
—
—
-6,922.55%
-22.29%
—
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions, except per-share amounts and margins. Weighted average shares are in millions. Interest expense and finance costs are positive costs. A negative amount on a gain (loss) or income (expense) line is a loss or an expense. EBITDA is operating income plus depreciation and amortization. Interest coverage is operating income divided by interest expense. More on our methodology.

Company profile

Industry
Services-Management Consulting Services (SIC 8742)
Listed as
NORD (Nasdaq)
Fiscal year ends
March 31
Incorporated in
DE
Headquarters
Beverly Hills, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1011060
Former names
EKIMAS Corp (until May 3, 2023); AdvanSource Biomaterials Corp (until Apr 3, 2020); CARDIOTECH INTERNATIONAL INC (until Sep 8, 2008)

Other Services-Management Consulting Services companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.